MethaShip Project: Renewable Methanol is ‘fuel with a future’

Much of the bunkering and transport infrastructure for Methanol already exists and can be extended further by adjustments to existing tanks and vessels.

Cross-industry research finds key advantages for use of methanol in medium speed marine engines for passenger shipping

Methanol is a clear, water-soluble, biodegradable fluid and in contrast to other alternative fuels such as LNG, it offers the crucial advantage of being very easy to handle.”

— Eelco Dekker, Methanol Institute Chief Representative Europe

BRUSSELS, BELGIUM, October 22, 2018 /EINPresswire.com/ — The Methanol Institute has welcomed the findings of the MethaShip research project which has concluded that renewable Methanol offers a long term solution for the industry’s ambitious carbon emission reduction strategy.

The MethaShip partners found that Methanol can offer a dramatic improvement in emissions reduction across multiple ship types once the IMO has established the statutory framework conditions necessary for an industry-wide reduction of CO2 emissions.

“The whole shipping sector is facing major challenges with ever stricter emission regulations for ships, paired with a growing environmental awareness among ship owners and passengers alike,” says MethaShip Project Leader Daniel Sahnen of MEYER WERFT. “Some technical and financial details still need to be clarified but in the medium term a breakthrough could be possible with Methanol as a fuel for a holistic reduction of CO2 emissions.”

The research project brought together partners from shipbuilding, classification, engine manufacturing and methanol production to investigate the potential of methanol as a fuel for cruise ships and RoRo passenger ferries. It included development of a potential cruiseship design featuring seven integrated storage tanks made of coated conventional mild steel.

“Methanol is a clear, water-soluble, biodegradable fluid and in contrast to other alternative fuels such as LNG, it offers the crucial advantage of being very easy to handle,” says Methanol Institute Chief Representative Europe Eelco Dekker. “In addition to its potential for long term emissions reduction, the easier storage and transport properties are a strong driver behind the growing interest in using methanol as a fuel for shipping.”

The MethaShip research project consortium consisted of the Flensburger Schiffbau-Gesellschaft, Lloyd’s Register, MEYER WERFT and associate partners Caterpillar, Helm AG and MAN Diesel & Turbo and was funded by the German Federal Ministry for Economic Affairs and Energy.

MethaShip’s key conclusions include:
• The properties of Methanol surpass other alternative fuels in shipping
• The major benefit is the storage at ambient temperature and ambient pressure without loss;
• In terms of ship design, Methanol is space-saving, simple and practical with the established advantages of a liquid fuel;
• Methanol offers compelling environmental properties and has the most promising lifecycle analysis when produced from renewable sources;
• An already widespread infrastructure and availability could be a key enabler for Methanol.

About MethaShip
A nationally-funded German research project, MethaShip drew on partners from shipbuilding, ship-safety, marine engines, methanol trading and production with the goal of examining the potential of methanol as a fuel for cruise ships and RoPax ferries.

About The Methanol Institute
First formed in 1989, the Methanol Institute (MI) serves as the trade association for the global methanol industry. MI represents the world’s leading methanol producers, distributors and technology companies from offices around the world. MI provides value to its members by ensuring safe handling of methanol and its derivatives, promoting methanol growth by furthering methanol as an essential chemical commodity and an emerging source of clean and renewable energy and influencing global regulatory and public policy initiatives that impact the methanol industry.

More information and documents: https://www.vsm.de/en/presseinformation/7818

Neville Smith
Mariner Communications
703-248-3636
email us here


Source: EIN Presswire

International Safety Equipment Association (ISEA) Opens Applications for Scholarship

$2,500 annual scholarship accepting applications through November 15, 2018

The annual scholarship in the amount of $2,500 is open to all college undergraduate students preferably enrolled in majors geared toward a Safety and Health career”

— Charles Johnson, President

ALEXANDRIA, VA, UNITED STATES, October 22, 2018 /EINPresswire.com/ — Charles Johnson, President of the International Safety Equipment Association (ISEA) is proud to announce applications are being accepted for the $2,500 annual Daniel K. Shipp Scholarship. Mr. Johnson and ISEA recognize the ambition, drive and dedication of those entering the Health and safety field. They also know the expenses associated in choosing this educational and career path. ISEA, actively working to enhance the field and entry of college students into the fields of occupational health and safety, developed the Daniel K. Shipp Scholarship Fund in 2017.

ISEA instituted the Daniel K. Shipp Scholarship as a legacy program to encourage new generations to enter the Safety and Health profession, and to help defray educational costs to eligible candidates as they pursue a career in the field of environmental and occupational health and safety. It was created to recognize the contribution that Mr. Shipp has made to ISEA and the safety and health of American workers during his 25 years as President of ISEA.

Mr. Shipp established ISEA as the “Voice of the Safety Equipment Industry.” He skillfully melded the hard work of ISEA members, to develop and implement the association’s benchmark of standards making, government relations and knowledge-sharing strategies. The positive impact on the industry is undeniable, and the health and life-saving impact for workers is inspirational. Mr. Shipp has rightfully established himself as a pillar of this industry.

The annual scholarship in the amount of $2,500 is open to all college undergraduate students preferably enrolled in majors geared toward a Safety and Health career, (such as, but not limited to, Environmental Science, Fire Protection, Health Physics, Industrial Engineering, Industrial Hygiene, Occupational Health, Safety) who are currently registered as full-time students in North America. A full-time student is one who is carrying 12 credit hours per semester, trimester or quarter. Applicants must have at least one full year of study remaining in their degree program students who share our vision to protect others.

This scholarship is awarded based on academic and extra-curricular achievement and financial need, and the recipients are selected by an independent review panel unaffiliated with the ISEA. Interested applicants can download an application form at https://safetyequipment.org/resources/isea-scholarship-fund/daniel-k-shipp-scholarship/, review the required information and the selection criteria or got to the ISEA website and click from the links below in the “Scholarship Resources” section. Completed application package must be digitally postmarked by 11:59 pm, November 15, 2018 and sent to DKS2018@veer90.com.

ABOUT ISEA
ISEA is the association for personal protective equipment and technologies – equipment and systems that enable people to work in hazardous environments. For more than 75 years, ISEA has set the standard for personal protective technologies, supporting the interests of its member companies who are united in the goal of protecting the health and safety of people worldwide.

ISEA is a recognized leader in the development of safety equipment standards, in the U.S. and around the world. It works with Congress and government agencies to consult with policy makers whose decisions affect the industry. It is a forum for information sharing and industry action, providing market insight and advocating for the use of personal safety equipment to keep workers safe.

Tanya Bronson
ISEA
703-525-1695
email us here


Source: EIN Presswire

Global Blood coagulation analyzer Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Market Research Nest Reports

Market Research Nest Reports

Blood coagulation analyzer Global Market 2018-2023 Report Analysis industry study, size, share, development, current trends, and forecast

PUNE, INDIA, October 22, 2018 /EINPresswire.com/ — MarketResearchNest.com adds “Blood coagulation analyzer Global Market 2018-2023 Report Analysis industry study, size, share, development, current trends, and forecast” new report to its research database

The Blood coagulation analyzer target global market analysis report will make the in-depth study and detailed research on the growth environment, Blood coagulation analyzer Market size, current trend, operation status and upcoming growth of the Blood coagulation analyzer Market. The information in the Blood coagulation analyzer research report has been collected and validated via a comprehensive research technique (primary research, secondary research, and SWOT analysis).

Get Request a sample copy @ https://www.marketresearchnest.com/report/requestsample/455155

Scope of Blood coagulation analyzer Market Report 2018-2023:-
Blood coagulation analyzer Worldwide Market Research Report examined the growth rate and the Blood coagulation analyzer Market value based on industry dynamics, growth-driving factors. The overall knowledge Blood coagulation analyzer Market is based on the recent industry news, scope, Blood coagulation analyzer opportunities and trends. Blood coagulation analyzer Market report serves a clear insight about the prominent factors that are witnessed to transform the worldwide market in the upcoming years.

This estimation covers Blood coagulation analyzer industry key vendor’s examination based on the company’s synopsis, Blood coagulation analyzer company profiles, financial study, market revenue, and opportunities by leading topographical regions. The Blood coagulation analyzer study of industry chain is offered to assist Blood coagulation analyzer market players build their business strategies for the future and evaluate the level of competition across the globe.

Market 2018 Key Segments Covered:
Key Players:
Roche Diagnostics, Sysmex, Gene-Tech Biomedicals, A&T, Sekisuichemical, Bexcoexports

Segmentation:
By Type: Automated Systems, Semi-Automated Systems, Manual Systems

By Applications: Hospitals, Clinical Laboratories, Point-of-Care Testing, Others

Highlights of the Blood coagulation analyzer Global Market Report Comprises:-
The differentiating strategies of the prominent Blood coagulation analyzer market players are included in the subsection of the synopsis. At the end of the synopsis, there is a pictorial representation of the development potential of the Blood coagulation analyzer market is covered. The Blood coagulation analyzer industry advancement trends and advertising channels have also been studied. The Blood coagulation analyzer research analysis includes all facets of the Blood coagulation analyzer market worldwide, which begins with the definition of the Blood coagulation analyzer industry and progress towards Blood coagulation analyzer market segments.

Order a Purchase Report copy @ https://www.marketresearchnest.com/report/purchase/455155

Blood coagulation analyzer Global Market Key Regions:-
North America, Europe, Asia-Pacific, South America, Middle East and Africa

Global Blood coagulation analyzer Market 2018-2023 Competitive Scenarios:
A various leading manufacturers included in the Blood coagulation analyzer global market research report are concentrating on development operations in regions, as they show potential Blood coagulation analyzer business opportunities. The leading manufacturers influence the operations in the Blood coagulation analyzer industry impute to their strong geographical extend and huge production facilities.

About Us:
MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the World’s most complete and recent database of expert insights on Global industries, organizations, products, and trends.

Mr Jeet
Market Research Nest
1-240-284-8070
email us here
Visit us on social media:
Facebook
Twitter
Google+
LinkedIn


Source: EIN Presswire

Global Blood Pressure Monitoring Market Top Manufacturers 2018-2023

Market Research Nest Reports

Market Research Nest Reports

Blood Pressure Monitoring Global Market 2018-2023 Report Analysis industry study, size, share, development, current trends, and forecast

PUNE, INDIA, October 22, 2018 /EINPresswire.com/ — MarketResearchNest.com adds “Blood Pressure Monitoring Global Market 2018-2023 Report Analysis industry study, size, share, development, current trends, and forecast” new report to its research database

The Blood Pressure Monitoring target global market analysis report will make the in-depth study and detailed research on the growth environment, Blood Pressure Monitoring Market size, current trend, operation status and upcoming growth of the Blood Pressure Monitoring Market. The information in the Blood Pressure Monitoring research report has been collected and validated via a comprehensive research technique (primary research, secondary research, and SWOT analysis).

Get Request a sample copy @ https://www.marketresearchnest.com/report/requestsample/455130

Scope of Blood Pressure Monitoring Market Report 2018-2023:-
Blood Pressure Monitoring Worldwide Market Research Report examined the growth rate and the Blood Pressure Monitoring Market value based on industry dynamics, growth-driving factors. The overall knowledge Blood Pressure Monitoring Market is based on the recent industry news, scope, Blood Pressure Monitoring opportunities and trends. Blood Pressure Monitoring Market report serves a clear insight about the prominent factors that are witnessed to transform the worldwide market in the upcoming years.

This estimation covers Blood Pressure Monitoring industry key vendor’s examination based on the company’s synopsis, Blood Pressure Monitoring company profiles, financial study, market revenue, and opportunities by leading topographical regions. The Blood Pressure Monitoring study of industry chain is offered to assist Blood Pressure Monitoring market players build their business strategies for the future and evaluate the level of competition across the globe.

Market 2018 Key Segments Covered:
Key Players:
GE Healthcare, Welch Allyn, AandD Medical, SunTech Medical, American Diagnostics, Withings, Briggs Healthcare, Kaz, Microlife, Rossmax, GF Health, Spacelabs Healthcare, Omron Healthcare, Healthcare

Segmentation:
By Type: Automated BP Monitors, Ambulatory BP Monitors

By Applications: Home Care, Hospitals

Highlights of the Blood Pressure Monitoring Global Market Report Comprises:-
The differentiating strategies of the prominent Blood Pressure Monitoring market players are included in the subsection of the synopsis. At the end of the synopsis, there is a pictorial representation of the development potential of the Blood Pressure Monitoring market is covered. The Blood Pressure Monitoring industry advancement trends and advertising channels have also been studied. The Blood Pressure Monitoring research analysis includes all facets of the Blood Pressure Monitoring market worldwide, which begins with the definition of the Blood Pressure Monitoring industry and progress towards Blood Pressure Monitoring market segments.

Order a Purchase Report copy @ https://www.marketresearchnest.com/report/purchase/455130

Blood Pressure Monitoring Global Market Key Regions:-
North America, Europe, Asia-Pacific, South America, Middle East and Africa

Global Blood Pressure Monitoring Market 2018-2023 Competitive Scenarios:
A various leading manufacturers included in the Blood Pressure Monitoring global market research report are concentrating on development operations in regions, as they show potential Blood Pressure Monitoring business opportunities. The leading manufacturers influence the operations in the Blood Pressure Monitoring industry impute to their strong geographical extend and huge production facilities.

About Us:
MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the World’s most complete and recent database of expert insights on Global industries, organizations, products, and trends.

Mr Jeet
Market Research Nest
1-240-284-8070
email us here
Visit us on social media:
Facebook
Twitter
Google+
LinkedIn


Source: EIN Presswire

Blood Glucose Monitoring Devices Market by Applications in Medical Industry 2018-2023

Market Research Nest Reports

Market Research Nest Reports

Blood Glucose Monitoring Devices Global Market 2018-2023 Report Analysis industry study, size, share, development, current trends, and forecast

PUNE, INDIA, October 22, 2018 /EINPresswire.com/ — MarketResearchNest.com adds “Blood Glucose Monitoring Devices Global Market 2018-2023 Report Analysis industry study, size, share, development, current trends, and forecast” new report to its research database

The Blood Glucose Monitoring Devices target global market analysis report will make the in-depth study and detailed research on the growth environment, Blood Glucose Monitoring Devices Market size, current trend, operation status and upcoming growth of the Blood Glucose Monitoring Devices Market. The information in the Blood Glucose Monitoring Devices research report has been collected and validated via a comprehensive research technique (primary research, secondary research, and SWOT analysis).

Get Request a sample copy @ https://www.marketresearchnest.com/report/requestsample/455114

Scope of Blood Glucose Monitoring Devices Market Report 2018-2023:-
Blood Glucose Monitoring Devices Worldwide Market Research Report examined the growth rate and the Blood Glucose Monitoring Devices Market value based on industry dynamics, growth-driving factors. The overall knowledge Blood Glucose Monitoring Devices Market is based on the recent industry news, scope, Blood Glucose Monitoring Devices opportunities and trends. Blood Glucose Monitoring Devices Market report serves a clear insight about the prominent factors that are witnessed to transform the worldwide market in the upcoming years.
This estimation covers Blood Glucose Monitoring Devices industry key vendor’s examination based on the company’s synopsis, Blood Glucose Monitoring Devices company profiles, financial study, market revenue, and opportunities by leading topographical regions. The Blood Glucose Monitoring Devices study of industry chain is offered to assist Blood Glucose Monitoring Devices market players build their business strategies for the future and evaluate the level of competition across the globe.

Market 2018 Key Segments Covered:
Key Players:
Terumo Corporation, Acon Laboratories, Roche Diagnostics, Johnson&Johnson, ARKRAY, Novo Nordisk, Medtronic, Abbott Laboratories, Ypsomed, Sanofi

Segmentation:
By Type: Self-Monitoring Devices, Continuous Glucose Monitoring Devices

By Applications: Hospitals and Diagnostic Laboratories, POL, Home-Care Settings

Highlights of the Blood Glucose Monitoring Devices Global Market Report Comprises:-
The differentiating strategies of the prominent Blood Glucose Monitoring Devices market players are included in the subsection of the synopsis. At the end of the synopsis, there is a pictorial representation of the development potential of the Blood Glucose Monitoring Devices market is covered. The Blood Glucose Monitoring Devices industry advancement trends and advertising channels have also been studied. The Blood Glucose Monitoring Devices research analysis includes all facets of the Blood Glucose Monitoring Devices market worldwide, which begins with the definition of the Blood Glucose Monitoring Devices industry and progress towards Blood Glucose Monitoring Devices market segments.

Order a Purchase Report copy @ https://www.marketresearchnest.com/report/purchase/455114

Blood Glucose Monitoring Devices Global Market Key Regions:-
North America, Europe, Asia-Pacific, South America, Middle East and Africa

Global Blood Glucose Monitoring Devices Market 2018-2023 Competitive Scenarios:
A various leading manufacturers included in the Blood Glucose Monitoring Devices global market research report are concentrating on development operations in regions, as they show potential Blood Glucose Monitoring Devices business opportunities. The leading manufacturers influence the operations in the Blood Glucose Monitoring Devices industry impute to their strong geographical extend and huge production facilities.
About Us:
MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the World’s most complete and recent database of expert insights on Global industries, organizations, products, and trends.

Mr Jeet
Market Research Nest
1-240-284-8070
email us here
Visit us on social media:
Facebook
Twitter
Google+
LinkedIn


Source: EIN Presswire

Nigeria – based consultancy company achieves faster turnaround while assuring Quality Management with MyEasyISO

VALLEY COTTAGE, NEW YORK, UNITED STATES, October 21, 2018 /EINPresswire.com/ — One of the fastest growing consultancy company based in Nigeria provides engineering and advisory services to clients in the oil and gas industry. Like many small-scale companies, this consultancy company wants to stay ahead of the competition in their sector and requires a solution to meet ISO regulation along with improving their services to keep the customer satisfied for the long-term approach.

The company's selection criteria when searching for the right solution include:

• Meet 100% requirement of ISO standard
• ISO Training and Implementation support
• Flexibility and ease of usage
• License cost

Their need brings them to MyEasyISO, which provides a configurable solution to meet all the ISO standard and many compliance requirements. MyEasyISO helps the organization to map out the process and can effortlessly see what’s going on in the organization at any time. It enables the organization to capture, track and maintain all the records through a centralized database.

MyEasyISO’s customer management module has the ability to track and monitor customer issues, complaints/feedback and maintain their records. It helps in managing complaint resolution planning, correction, root cause analysis, corrective actions and effective evaluation of the corrective actions for various complaints.

With MyEasyISO, managing the operational processes in a web-based solution enable the company to streamline their operations in line with quality compliance and economic challenges. MyEasyISO system allows the organization to be able to rapidly react to changing business needs as well as customer needs.

MyEasyISO helped many organizations to achieve many operational goals including:

• Faster turnaround on the return of investments
• Eliminating parallel work
• Saving cost and time
• Significant improvement in response and closure of customer issues
• Signification reduction of nonconformance
• Keeps the system always audit-ready by meetings all the requirement

MyEasyISO experts and consultants provide a complete guide to all the employees in the organization for effective onboarding support and implementation support to enable users to use the system and help them get certified by the best of the certification bodies. MyEasyISO’s affordable pricing, intuitive ability, the robust reporting capabilities and 24/7 support from QHSE experts sets this solution apart from other software solution vendors in the market.

About MyEasyISO

MyEasyISO is a comprehensive ISO QHSE software to implement and manage ISO 9001, ISO 14001, ISO 45001 and ISO 22000 standards effectively. Its competitive, practical and user-friendly solution makes the ISO compliance value adding, fast and simple.

It is recognized as one of the best quality management software solutions in numerous independent surveys and reviews covering customer satisfaction, simplicity, ease of deployment, comprehensive coverage of various requirements, support, value for money etc.

With more than 4000 clients across the world, MyEasyISO is gaining fast popularity in the market and has helped clients across all industries by improving business performance, implementing, certifying and maintaining ISO standards.

Wondering how MyEasyISO can help with successful ISO implementation and certification? Contact us or Visit our website for a free consultation with one of our experts.

Sree Vidhya
Effivity Technologies LLC
+1-800-233-1425
email us here


Source: EIN Presswire

The Rare Earths Investor Announces a New Website Resource for Self Directed Investors.

New, one stop Rare Earths website resource with multiple up to date content areas, blog and cutting edge forum communication tools.

KENT, OHIO, USA, October 19, 2018 /EINPresswire.com/ — The Rare Earths Investor announces the opening of www.rareearthsinvestor.com. A website designed for self-directed investors who need access to multiple sources of up to date Rare Earths information (i.e., daily news, articles, presentations, research and company websites, etc.) all in one place, ready to assist investment decision making.

Move easily between multiple Rare Earths information sources to enrich your investment due diligence. Also, challenge your thinking with a free account to a forum designed for investors to utilize both traditional and cutting-edge communication tools. Post and reply to the Blog, and on boards focused on both the general Rare Earths sector and all the major companies.

Then, new to Rare Earths forum interaction, communicate on www.rareearthsinvestor.com with other online users in real time, via instant messaging and ‘chat’ room dialogue. Chat online in private with a colleague or in larger open discussion groups. You can arrange group (or private) discussions on self-selected topics; even invite a Rare Earths company representative to chat online with interested forum investors.

www.rareearthsinvestor.com is a one stop Rare Earths website, free of distracting advertisements and also offering an interactive Blog to further challenge and encourage critical thinking.

If you have a serious investor interest in the Rare Earths sector and want to add another specific resource for helping with your due diligence, then use both the free content and forum communication tools at www.rareearthsinvestor.com.

John Jones
Rare Earths Investor
+13306788160
email us here
Visit us on social media:
Twitter


Source: EIN Presswire

NEXIEN BioPharma Inc. Announces Symbol Change to NXEN

Nexien BioPharma's new trading symbol: NXEN

Nexien BioPharma Inc (OTCQB:NEXN)

The new symbol, NXEN, is more reflective of our Corporate name, Nexien BioPharma and our objective of being a global leader in the cannabinoid science and the development of pharmaceuticals”

— Alain Bankier, Interim CEO

DENVER, CO, USA, October 18, 2018 /EINPresswire.com/ — Nexien BioPharma Inc. (OTCQB: NXEN) (formerly Intiva BioPharma Inc.) (the "Company") today announced that effective as of October 19, 2018, the Company will trade on the OTC QB under the new stock symbol NXEN.

Commenting on the symbol change, Alain Bankier, the Interim CEO of Nexien stated, “ The new symbol, NXEN, is more reflective of our Corporate name, Nexien BioPharma and our objective of being a global leader in the further evolution of cannabinoid science and the development of Food and Drug Administration ("FDA") compliant pharmaceuticals based on specific cannabinoid molecules.”
About Nexien BioPharma
Nexien BioPharma is a US-based pharmaceutical development company engaged in the formulation, development, and commercialization of cannabinoid-based pharmaceuticals in accordance with U.S. Food and Drug Administration ("FDA") pre-clinical and clinical pathways, to address a broad range of medical conditions and disorders.
Nexien BioPharma's drug development strategy consists of:
• The determination of medical conditions and disorders that could potentially benefit from cannabinoid-based formulations;
• Conducting "freedom to operate" investigations on these conditions;
• The preparation of patent applications and the prosecution of such application and/or the licensing of existing patents;
• Identifying the regulatory pathway with the FDA; and
• Proceeding with pre-clinical and clinical development activities in accordance with FDA protocols for submission to obtain approval for the particular product(s).
Current financial disclosure and Real-Time Level 2 quotes for Nexien Biopharma are available at www.otcmarkets.com or at www.INTIVABioPharma.com.

Nexien Disclosure Notice: This press release contains "forward-looking statements. For this purpose, any statements contained herein or which are otherwise made by or on behalf of Nexien BioPharma that are not statements of historical facts may be deemed forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "to," "plan," "expect," "believe," "anticipate," "intend," "could," "should," "would," "estimate," or "continue," or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. Readers are cautioned that all forward-looking statements involve risk and uncertainties, which may cause results to differ materially from those, set forth in the statements. Such risks and uncertainties include, but are not limited to the following: the success of research and development activities and the speed with which regulatory authorizations and product launches may be achieved; government regulation generally; competitive developments; the ability to successfully market products domestically and internationally; difficulties or delays in manufacturing or issues relating to manufacturing capacity; commercial obstacles to the successful introduction of brand products generally; legal defense costs, insurance expenses, settlement costs, and the risk of an adverse decision or settlement relating to product liability, patent protection, governmental investigations, and other legal proceedings; Nexien BioPharma's ability to acquire and protect patents and other intellectual property both domestically and internationally; the absence of certainty regarding the receipt of required regulatory approval or the timing or terms of such approvals; any changes in business, political and economic conditions; business interruption due to events outside of Nexien BioPharma's control.
Readers are cautioned not to place reliance on these forward-looking statements, which are valid only as of the date they were made. Nexien BioPharma undertakes no obligation to update or revise any forward-looking statements to reflect new information or the occurrence of unanticipated events or otherwise, except as expressly required by law.

Mark Lubchenco
Nexien BioPharma Inc
303 495 7583
email us here


Source: EIN Presswire

ComplianceOnline Announces Seminar on Advertising and Promotional Requirements for Drugs and Medical Devices

ComplianceOnline and FDA Lawyer, Michael A Swit, Esq. will conduct a two day seminar on Advertising and Promotional Requirements for Drugs and Medical Devices.

PALO ALTO, CA, USA, October 17, 2018 /EINPresswire.com/ — Led by well-known FDA Lawyer Michael Swit, ComplianceOnline’s Live Seminar on Advertising and Promotional requirements for drugs and medical devices returns to Boston in 2018. The two-day training program will address in detail FDA requirements for drug and device firms as well as recent current hot buttons in FDA enforcement activity for the advertising arena.

Given the endless updates in the regulated industry, each session in the seminar will discuss these industry updates and focus on best practices to avoid Warning Letters and other regulatory enforcement actions.
The seminar will cover topics such as distinctions between labels, labeling and advertising, and how that impacts FDA's powers, how to properly position Direct-to-Consumer (DTC) promotions, the Dos and Don'ts of promoting products on the internet, including social media sites such as Facebook and Twitter, the perils of off-label promotion and much more.

The 2016 & 2017 participation for this event from various healthcare and pharma organizations, such as Health Canada, Depomed, Pfizer, Dr Reddy's Laboratories, SSCOR, Inc., GSK, Grifols Diagnostic Solutions, Inc., Gilead Sciences, Adamas Pharmaceuticals, Inc. and others, have made the event an industry platform to reckon with.

Seminar instructor Michael A. Swit, Esq., has been tackling critical FDA legal and regulatory issues since 1984. His experience includes FDA development strategies, compliance and enforcement initiatives, recalls and crisis management, submissions and related traditional FDA regulatory activities, labeling and advertising, and clinical research efforts. Mr. Swit has lectured and written on a variety of subjects relating to FDA law, regulation and related commercial activities and is a former member of the Food & Drug Law Journal Editorial Board.

This in-person training will assist sales, marketing, medical affairs, legal, regulatory, and compliance professionals within an organization.

For more information or to register for the seminar, please visit our website.

DAY 01 Agenda (8:30 AM – 4:30 PM)

I. Understanding the Basics (Who Has Jurisdiction,Labeling vs. Advertising, Device rules, DTC advertising, Comparative Claims, Detailing and Sampling, How FDA learns of violations)
II. Scientific Exchange (Guidances on Dissemination of Scientific Information, Risks involved in Off-Label Statements, Procedural Requirements and Unsolicited Requests for Information)
III. First Amendment (Understanding “Commercial Speech” Doctrine, FDA and the Regulation of Advertising)
IV. Websites & Social Media (FDA Policies on the Internet, Recent FDA Enforcement Activities, How to Handle at the Company Levels)

DAY 02 Agenda (8:30 AM – 4:30 PM)

V. Enforcement Trends (FDA Hot Buttons, FTC, Private Litigation – Understanding)
VI. False Claims Act and Criminal Liability (Key Settlements,Responsible Corporate Official Liability)
VII. Handling at the Company Level (Compliance Programs, Internal processes)

Dates: Thursday, November 1, 2018 (8.30 AM- 4.30 PM) and Friday, November 2, 2018 (8.30 AM- 4.30 PM)
Location: Boston, MA
Registration Cost: $1,599.00 per registration
Early bird discounts: For discounts on early registrations, please click here.

Register by phone: Please call our customer service specialists at +1-888-717-2436 or email to customercare@complianceonline.com

For more information on ComplianceOnline or to browse through our trainings, please visit our website https://www.complianceonline.com

About ComplianceOnline

ComplianceOnline is a leading provider of regulatory compliance trainings for companies and professionals in regulated industries. ComplianceOnline has successfully trained over 55,000 professionals from 15,000 companies to comply with the requirements of regulatory agencies. ComplianceOnline is headquartered in Palo Alto, California and can be reached at https://www.complianceonline.com. ComplianceOnline is a MetricStream portal. MetricStream (www.metricstream.com) is a market leader in Enterprise-wide Governance, Risk, Compliance (GRC) and Quality Management Solutions for global corporations.

Priyabrata Sahoo
ComplianceOnline
+1-888-717-2436
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

ITOM Specialist, Aspire Systems Sponsoring ServiceNow Now Summit in Amsterdam

Aspire Systems is sponsoring Now Summit, Amsterdam to collaborate and partner with enterprises looking to build an ITOM Solution using ServiceNow platform.

We are specializing in ServiceNow ITOM to enable enterprises build an efficient ITOM solution. With a new development center in Poland, our ServiceNow practice is growing exponentially in Europe.”

— Ananth Krishnamoorthy, Director of ServiceNow Practice

AMSTERDAM, NETHERLANDS, October 17, 2018 /EINPresswire.com/ — Aspire Systems, a global technology services firm, announced today it is a gold sponsor of ServiceNow's Now Summit in Amsterdam. The summit is scheduled on October 25th at Beurs van Berlage in Amsterdam. Aspire will be looking forward to meet and help delegates that are currently using ServiceNow and planning to implement ServiceNow to meet their organizational needs. Our experts will consult the delegates on how to enable ServiceNow ITOM to achieve their business goals and ROI in a short span of time.

Now Summit is a place to learn, connect, and get inspired by ServiceNow visionaries, customers, and partners. This complimentary 1 day program delivers the best of Knowledge 2018 content, ServiceNow’s annual global ServiceNow event which took place in Las Vegas. Experience targeted attends the keynote presentations, education sessions, and additional networking opportunities in ExpoNow. Discover how ServiceNow can help you deliver great employee and customer experiences.

Aspire is sponsoring ServiceNow’s Knowledge and Now Summit conferences for the past three years. Our core focus lies in helping enterprises build an efficient and cost effective ITOM solution that simplifies their IT team’s job. Aspire has strong capabilities to implement ITOM modules – Discovery, Event Management, Orchestration, Service Mapping, Cloud Management, well within your budget limits – through their offshore, onsite and near shore delivery models.

“This is the second consecutive year we are sponsoring Now Summit in Amsterdam. Our ServiceNow practice is growing exponentially in the EU regions, we have also setup a new development center in Poland, this Now Summit falls in right time for Aspire. We are really excited to enable enterprises leverage ITOM modules in resolving today’s Enterprise Service Management challenges.” said Ananth Krishnamoorthy, Director of Infrastructure Support and ServiceNow Implementation Practice.

Aspire invites attendees to its booth to participate in their discussions about ITOM and take away the best practices back home. Registrations can also prebook their sessions with our consultants online.

Kaviarasan Selvaraj
Aspire Systems
+31308009217
email us here


Source: EIN Presswire